Globus Medical Inc. (GMED)
Globus Medical Statistics
Share Statistics
Globus Medical has 159.97M shares outstanding. The number of shares has increased by 0.59% in one year.
| Shares Outstanding | 159.97M |
| Shares Change (YoY) | 0.59% |
| Shares Change (QoQ) | 0.56% |
| Owned by Institutions (%) | 80.12% |
| Shares Floating | 158.38M |
| Failed to Deliver (FTD) Shares | 89 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 2.5M, so 1.84% of the outstanding shares have been sold short.
| Short Interest | 2.5M |
| Short % of Shares Out | 1.84% |
| Short % of Float | 1.85% |
| Short Ratio (days to cover) | 2.23 |
Valuation Ratios
The PE ratio is 109.01 and the forward PE ratio is 26.81. Globus Medical's PEG ratio is -3.6.
| PE Ratio | 109.01 |
| Forward PE | 26.81 |
| PS Ratio | 4.46 |
| Forward PS | 3.3 |
| PB Ratio | 2.69 |
| P/FCF Ratio | 27.7 |
| PEG Ratio | -3.6 |
Enterprise Valuation
Globus Medical Inc. has an Enterprise Value (EV) of 6.08B.
| EV / Earnings | 59.03 |
| EV / Sales | 2.41 |
| EV / EBITDA | 12.83 |
| EV / EBIT | 36.63 |
| EV / FCF | 15 |
Financial Position
The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.13.
| Current Ratio | 2.54 |
| Quick Ratio | 1.77 |
| Debt / Equity | 0.13 |
| Total Debt / Capitalization | 11.39 |
| Cash Flow / Debt | 0.97 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.02% and return on capital (ROIC) is 3%.
| Return on Equity (ROE) | 0.02% |
| Return on Assets (ROA) | 0.02% |
| Return on Capital (ROIC) | 3% |
| Revenue Per Employee | $475,350 |
| Profits Per Employee | $19,430.94 |
| Employee Count | 5,300 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 1.57 |
Taxes
| Income Tax | 17.74M |
| Effective Tax Rate | 0.15 |
Stock Price Statistics
The stock price has increased by 41.54% in the last 52 weeks. The beta is 1.19, so Globus Medical's price volatility has been higher than the market average.
| Beta | 1.19 |
| 52-Week Price Change | 41.54% |
| 50-Day Moving Average | 83.78 |
| 200-Day Moving Average | 76.36 |
| Relative Strength Index (RSI) | 38.43 |
| Average Volume (20 Days) | 1.47M |
Income Statement
In the last 12 months, Globus Medical had revenue of 2.52B and earned 102.98M in profits. Earnings per share was 0.76.
| Revenue | 2.52B |
| Gross Profit | 1.48B |
| Operating Income | 165.99M |
| Net Income | 102.98M |
| EBITDA | 473.73M |
| EBIT | 165.99M |
| Earnings Per Share (EPS) | 0.76 |
Balance Sheet
The company has 784.44M in cash and 537.19M in debt, giving a net cash position of 247.25M.
| Cash & Cash Equivalents | 784.44M |
| Total Debt | 537.19M |
| Net Cash | 247.25M |
| Retained Earnings | 1.15B |
| Total Assets | 5.25B |
| Working Capital | 1.32B |
Cash Flow
In the last 12 months, operating cash flow was 520.64M and capital expenditures -115.43M, giving a free cash flow of 405.21M.
| Operating Cash Flow | 520.64M |
| Capital Expenditures | -115.43M |
| Free Cash Flow | 405.21M |
| FCF Per Share | 2.99 |
Margins
Gross margin is 58.9%, with operating and profit margins of 6.59% and 4.09%.
| Gross Margin | 58.9% |
| Operating Margin | 6.59% |
| Pretax Margin | 4.79% |
| Profit Margin | 4.09% |
| EBITDA Margin | 18.8% |
| EBIT Margin | 6.59% |
| FCF Margin | 16.08% |
Dividends & Yields
GMED does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 1.03% |
| FCF Yield | 3.44% |
Analyst Forecast
The average price target for GMED is $95.5, which is 29.7% higher than the current price. The consensus rating is "Buy".
| Price Target | $95.5 |
| Price Target Difference | 29.7% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
Scores
| Altman Z-Score | 7.85 |
| Piotroski F-Score | 7 |